ArticleIntestinal research2018

Comparison of efficacy of once daily multimatrix mesalazine 2.4 g/day and 4.8 g/day with other 5-aminosalicylic acid preparation in active ulcerative colitis: a randomized, double-blind study.

Haruhiko Ogata et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.